Aytu Biopharma (AYTU) Deferred Taxes (2014)
Aytu Biopharma (AYTU) reported Deferred Taxes of -$1.0 for Q4 2014, up 100.0% quarter-over-quarter from -$23909.0 in Q3 2014.
Aytu Biopharma (AYTU) Deferred Taxes (2014) Analysis & Trends
Aytu Biopharma (AYTU) has 1 years of Deferred Taxes data on file, last reported at -$1.0 in Q4 2014.
- Deferred Taxes for Q4 2014 came in at -$1.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was -$1.0 (changed N/A YoY), and the FY2015 annual result was -$23910.0, up 97.06% from the prior year.
- Deferred Taxes advanced to -$1.0 in Q4 2014 per AYTU's latest filing, from -$23909.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at -$1.0 in Q4 2014 and troughed at -$23909.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -22.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 34.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 25.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14,341.73 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -61.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -8.79 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -13.98 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 19.33 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -1.00 |
| Sep 30, 2014 | -23,909.00 |